Brief: I'rom Group unit signs iPS cell tech related license agreement with Q-State Biosciences
Jan 9 (Reuters) - I'rom Group Co Ltd 2372.T
* Says co's wholly owned unit ID Pharma signs iPS cell
(induced
pluripotent stem cell) technology related license agreement with
U.S.-based firm Q-State Biosciences Inc
Source text in Japanese: https://goo.gl/xfg8so
Further company coverage: 2372.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: Tingting.liu@thomsonreuters.com@reuters.net))
Recent news on I'rom Co
See all newsTo Retire Treasury Shares Worth 1.89% Of Outstanding Stock On May 13
9-MTH group results
Blackstone-Backed Group To Launch Management Buyout Tender Offer For Its Shares On Feb 3 After Clearing Regulatory Process In Australia
Brief: ACCC Says Blackstone Acquisition Of Clinical Trial Service Provider Not Opposed
Brief: Australia's ACCC Says Blackstone's Proposed Acquisition Of I'Rom Raises Concerns